News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Pre-Clinical
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS 3/3/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/3/2015
Pharmacyclics (PCYC) Release: In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3/2/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/2/2015
Alkermes plc (ALKS) Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases 3/2/2015
Gilead (GILD) Announces Preclinical Data For An Investigational TLR7 Agonist In SIV-Infected, Virally Suppressed Monkeys 2/26/2015
Bayer HealthCare (BAY) Strikes Deal With Mission Bay Incubator Tenant Aronora 2/25/2015
Lixte Biotechnology's Lead Compound Reported To Be Active Against Hematologic Cancers In Pre-Clinical Studies 2/25/2015
Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm Therapeutics (KPTI)'s SINE Compounds In The Treatment Of Multiple Sclerosis 2/24/2015
Celsion Corporation (CLSN) Presents Clinical And Preclinical Data For GEN-1 IL-12 Immunotherapy In Ovarian Cancer At The Molecular Medicine TRI-Conference 2/20/2015
Pharmacyte Biotech Initiates Expanded Follow-Up Study In The United States On The Accumulation Of Malignant Ascites Fluid 2/19/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Vaccinex, Inc. Announces The Publication Of Data Demonstrating Preclinical Efficacy In An Animal Model Of Huntington Disease 2/18/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Anatara Lifesciences Reports Successful DetachTM Trial Results 2/18/2015
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015
Halozyme Therapeutics, Inc. (HALO) Announces Preclinical Study Results Of Pegph20 Published In Molecular Cancer Therapeutics 2/17/2015
Tiny Startup Spyryx Looks to One-Up Vertex Pharmaceuticals (MA) (VRTX) With One-Size-Fits-All Cystic Fibrosis Therapy 2/13/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015
Heat Biologics Presents Positive Preclinical Data On A Novel Approach To Combination Immunotherapy At The Keystone Symposia On Tumor Immunology 2/11/2015
12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 ASM Biodefense And Emerging Diseases Research Meeting In Washington, DC 2/11/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/10/2015
Amicus Therapeutics, Inc. (FOLD) Presents Preclinical Data On Next-Generation Pompe ERT At Worldsymposium 2015 2/10/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Publication Of Preclinical Data For Supinoxin (RX-5902) Demonstrating Mechanism Of Action 2/9/2015
Hemispherx Biopharma (HEB) Posts USAMRIID Ebola Study Concluding Ampligen Produced 100% Survival Rate In Rodents With 100% Mortality In Placebo 2/9/2015
VBL Therapeutics (VBLX) To Present Preclinical Data At Keystone Symposium On Liver Metabolism And Nonalcoholic Fatty Liver Disease 2/9/2015
Lycera Announces Research Showing Promising Anti-Cancer Activity Of Novel, Oral Immunotherapy Candidates 2/9/2015
Anavex (AVXL) Confirms Positive Preclinical Epilepsy Data For ANAVEX 2-73 - Validation As Potential Platform Drug For Multiple Neurodegenerative Diseases 2/9/2015
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes 2/2/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Vaccinex, Inc. Announces Groundbreaking Preclinical Data Demonstrating An Immunomodulatory Role For Anti-SEMA4D Antibody Blockade In Colon And Breast Cancer 1/27/2015
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015
MYOS (MYOS)'s Preclinical Study Of Fortetropin's™ Mechanism Of Action Demonstrate Regulatory Effects On Three Key Muscle Health Pathways 1/26/2015
RestorGenex Announces Presentation Of Scientific Data On RES-529 For The Treatment Of Glioblastoma At Keystone Symposia On PI 3-Kinase Signaling Pathway 1/23/2015
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences  (NVLT) Fluorescence Cancer-Targeting Agents Chosen For The Cover Of Neurosurgery 1/22/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease 1/21/2015
Karcinolys’ Myb34.5 Oncolytic Virus Preclinical Results In Pancreatic Cancer Featured In Peer-Reviewed Journal "Human Gene Therapy" 1/21/2015
Verastem, Inc. (VSTM) Announces Publication Of Scientific Data For VS-5584 In Cancer Research 1/16/2015
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum 1/12/2015
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015
PHARNEXT's Pleotherapy Shows Synergistic Effects With PXT-864 In Alzheimer's Disease Through Preclinical Data Published In Nature's Scientific Reports 1/8/2015
Bio-Path Holdings, Inc. (BPTH)’ Liposomal Grb-2 Featured In Peer-Reviewed Journal “Expert Opinion On Drug Delivery” 1/7/2015
Minerva Neurosciences, Inc. (NERV) Reports Positive Data Showing An Analog Of Minerva's MIN-301 Compound Improves Symptoms Of Parkinson's Disease In Primates 1/6/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces Publication Of Preclinical Data For RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells 1/6/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Biocryst Pharmaceuticals (BCRX) Announces Study Results For BCX4430 In A Non-Human Primate Model Of Ebola Virus Infection 12/23/2014
Bio-Path Holdings, Inc. (BPTH) To Initiate Development Of Liposomal Bcl-2 In Follicular Lymphoma 12/22/2014
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection 12/22/2014
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study 12/19/2014
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin 12/11/2014
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014
NIH Publishes Results Of Preclinical Collaboration With ChromaDex, Inc. Showing Potential Benefit Of Nicotinamide Riboside 12/10/2014
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014
Fate Therapeutics (FATE) Highlights Effects Of Nutrient-Rich Media On Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood 12/9/2014
GlycoMimetics, Inc. (GLYC) Highlights Potential Therapeutic Benefits Of Its Novel E-Selectin Antagonist At 56th American Society of Hematology Annual Meeting 12/9/2014
Epizyme (EPZM) First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma 12/9/2014
Fate Therapeutics (FATE) Unveils Preclinical Findings Of Newly-Identified Small Molecule Modulator Combination For Ex Vivo Programming Of Mobilized Peripheral Blood 12/8/2014
Blueprint Medicines Debuts Comprehensive Preclinical Data Set On First Selective Drug For Patients With Systemic Mastocytosis At 2014 American Society of Hematology Annual Meeting 12/8/2014
Geron Corporation (GERN) Announces Publication Of Preclinical Data On Imetelstat Activity In Acute Myelogenous Leukemia 12/8/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014
ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy 12/4/2014
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models 12/3/2014
Preclinical Data Published On AM-Pharma Holding BV’s recAP To Treat Ultra Rare Disease Hypophosphatasia 12/2/2014
AB Science (AB.PA) Advances Ultra-Selective SYK Kinase Inhibitor Into Full Preclinical Development 12/1/2014
Antibe Therapeutics Inc. Provides Update On Its Acute Pain Drug ATB-352 11/25/2014
Luoxis Announces Presentation Of Multiple Studies Validating Redoxsys As A Rapid And Non-Invasive Means Of Assessing Oxidative Stress 11/24/2014
Inovio Pharmaceuticals (INO) Melanoma DNA Immunotherapy Inhibits Tumor Growth And Increases Survival In Preclinical Study 11/20/2014
Nektar Therapeutics (CA) (NKTR) Presents Preclinical Study Findings For Etirinotecan Pegol (NKTR-102) In Combination With A PARP Inhibitor In BRCA1-Deficient Cancer Model 11/20/2014
Kolltan Pharmaceuticals Inc. Presents KTN3379 Clinical And Preclinical Data At International Cancer Meeting 11/20/2014
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014
Kadmon Corporation Presents Preclinical Data On Bi-Functional Anti-PD-L1/IL-15 Fusion Protein At EORTC-NCI-AACR Symposium 11/19/2014
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On RNAi Therapeutic Programs For Cardio-Metabolic Diseases At American Heart Association Scientific Sessions 2014 11/18/2014
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014
Enzyme Bio-Systems Ltd. Announces An Independent Research Group Reported Breast Cancer Preventive Efficacy For A Novel Synthetic Triterpenoid 11/17/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AstraZeneca PLC (AZN) To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta 11/13/2014
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
Cortice Biosciences Announces Results From Studies Evaluating Pipeline Candidates TPI 287 And CRT 001 In Preclinical Models Of Tauopathies And Alzheimer's Disease 11/12/2014
Preclinical Data For GenVec Inc. (GNVC)'s RSV Vaccine Candidate Presented At The 9th RSV Symposium 11/11/2014
SanguiBioTech GmbH: Preclinical Trials Demonstrate: Sangui Hemoglobin Preparation Improves Oxygen Supply Of Vital Organs 11/11/2014
TetraLogic Pharmaceuticals (TLOG) Announces Results Of Preclinical Studies In Hepatitis B 11/10/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014
Innovimmune Biotherapeutics, Inc. To Present Superior Preclinical Therapeutic Efficacy Results In Rheumatoid Arthritis Of Its INV-17 ROR Gamma T Inhibitor Program At The 2014 American College of Rheumatology Annual Meeting 11/5/2014
Innate Pharma (IPH.PA ) : IPH4102 Preclinical Data Published In "Cancer Research" 11/3/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Loxo Oncology (LOXO) To Present Pre-Clinical Data On LOXO-101 At Upcoming European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 10/30/2014
CytRx Corporation (CYTR) Announces Publication Of Preclinical Glioblastoma Data In Neoplasia 10/29/2014
Celsion Corporation (CLSN) Presents Preclinical Data For Its TheraSilence™ Platform At The miRNA World Conference Workshop On miRNA Delivery 10/29/2014
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure 10/27/2014
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014
Immunovaccine Inc. Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine 10/21/2014
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014
VG Life Sciences, Inc. (VGLS) Release: New Data Implicate Components Of Adaptive Immunity In Traumatic Brain Injury 10/20/2014
Epizyme (EPZM) Presents Pre-Clinical Data On EZH2 Inhibitor EPZ-6438 (E7438) In Models Of Synovial Sarcoma 10/17/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Tekmira (TKMR) Presents Results Of Preclinical Studies With Hepatitis B Therapeutic 10/16/2014
Cellular Biomedicine Group (CBMG) Launches Pre-Clinical Research Study For Chronic Obstructive Pulmonary Disease (COPD) 10/16/2014
BioSpecifics Technologies Corporation (BSTC) Announces Presentation Of Encouraging Preclinical Data For CCH From Collaborative Uterine Fibroid Study With Duke Medicine 10/16/2014
HHS Contracts With Profectus BioSciences, Inc. To Manufacture Ebola Vaccine For Animal Safety Studies 10/16/2014
Dicerna Pharmaceuticals (DRNA) Presents Preclinical Data For Investigational RNAi Therapeutic DCR-PH1 In Primary Hyperoxaluria Type 1 (PH1) At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society 10/15/2014
Alnylam Pharmaceuticals (ALNY) Presents New Clinical And Pre-Clinical Data On RNAi Therapeutics At 10th Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
Regulus Therapeutics, Inc. Presents New Preclinical Data On Multiple Programs And Provides Portfolio Overview At 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014
Compugen Ltd. (CGEN) Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer AG (BAYZF) 10/14/2014
Tekmira (TKMR) To Present HBV Pre-Clinical Data At Meeting Of The Oligonucleotide Therapeutics Society 10/10/2014
Shionogi, Inc. Release: Novel Siderophore Cephalosporin S-649266 Pre-Clinical Results Suggest Potent Activity Against Multidrug-Resistant Gram-Negative Pathogens 10/9/2014
Kadimastem Received A Quick Response From The FDA: The Development Process For The Stem Cell-Based Drug For ALS Is Expected To Be Significantly Shortened 10/7/2014
Protein Sciences Corporation Expects To Begin Testing Ebola Vaccine 10/7/2014
Kadimastem Approached The FDA Regarding Its ALS Treatment 10/6/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014 10/2/2014
Regen BioPharma Completes Preclinical Experiments For dCellVax Breast Cancer Immune Therapy 10/2/2014
REGENXBIO's NAV® Technology Demonstrates Correction Of Cardiovascular Symptoms Of MPS I In Animal Model 9/30/2014
OncoMed Pharmaceuticals, Inc. (OMED) Announces Selection Of First Small Molecule Product Candidate Targeting The Wnt Pathway Under Collaboration With Bayer Pharma AG 9/30/2014
Cell Reports Publication On The Mechanism Of Action Of NOXXON’s Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) In Preclinical Multiple Myeloma Models 9/26/2014
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
Sirona Biochem Launches Anti-aging Preclinical Studies 9/23/2014
Research Findings Demonstrate miRagen Therapeutics’ Drug Reverses Pulmonary Fibrosis 9/22/2014
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 9/22/2014
Nektar Therapeutics (CA) (NKTR) Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting 9/19/2014
Cyclacel Pharmaceuticals, Inc. (CYCC)'s CYC065 CDK Inhibitor Demonstrates Therapeutic Potential In Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements 9/18/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data With ALN-CC5, A Subcutaneously Administered Rnai Therapeutic Targeting Complement Component C5 In Development For The Treatment Of Complement-Mediated Diseases 9/16/2014
Celator Pharmaceuticals, Inc. Announces Publication Of Preclinical Data For CPX-351 In Acute Lymphoblastic Leukemia Models 9/15/2014
Viamet Pharmaceuticals Receives Orphan Drug Designation For VT-1129 9/11/2014
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity Against Complicated Urinary Tract Infection Pathogens 9/8/2014
Blueprint Medicines Presents Positive Data On BLU-554 For Hepatocellular Carcinoma 9/8/2014
Shionogi & Co., Ltd. Presents Pre-Clinical And Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens 9/8/2014
Novan Therapeutics’s Nitric Oxide Drug Candidate Inhibits Growth Of Papillomavirus In Translational Animal Model 9/8/2014
Arch Therapeutics Announces Positive Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device™ 9/8/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens 9/8/2014
Johnson & Johnson (JNJ) Jumps Into The Ebola Race With Collaboration Of Crucell (JNJ) And Bavarian Nordic (BAVA.CO); Human Trials To Start In Early 2015 9/4/2014
Tricida Announces In-House Discovered Clinical Candidate In Cardiorenal Disease 9/4/2014
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014
Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of Their First-In-Class Inflammation Assets, RP6503 And RP3128 For Treatment Of Various Respiratory Diseases 9/3/2014
Chimerix, Inc. (CMRX)'s Brincidofovir Has In Vitro Activity Against Ebola 9/3/2014
Aerpio Announces Publication Of Preclinical Data On AKB-9778 For Common Eye Diseases 9/3/2014
Galleon Pharmaceuticals, Inc. Announces Publication Of Proof-Of-Concept Clinical Studies For GAL-021, Projected Use For The Emerging Perioperative Sleep Apnea Epidemic 9/2/2014
SAGE Therapeutics Presents New Preclinical Data On SAGE-217 At Eilat Conference On New Anti-Epileptic Drugs 9/2/2014
Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks 8/29/2014
IntelliPharmaCeutics Augments Its Rexista™ Oxycodone Development Program With Novel Overdose Deterrence Technology 8/29/2014
Cannabis Science Inc. Provides Updated Guidance On Its Current Pre-Clinical Drug Development Programs Beginning With The Scientific Cannabis Cultivation Programs In Europe And North America, Testing Multiple Cannabis Strains For Multiple Critical Ailments 8/27/2014
TetraLogic Pharmaceuticals (TLOG) To Present Data From Pre-Clinical Studies With Hepatitis B At The 2014 International Meeting On Molecular Biology Of Hepatitis B Viruses 8/27/2014
REGENX Biosciences, LLC: Attacking A Rare Disease At Its Source With Gene Therapy 8/27/2014
Arch Therapeutics Announces Positive Preclinical Data From Its Study Of AC5 Surgical Hemostatic Device™ In Animals On Blood Thinner 8/25/2014
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Glioblastoma Multiforme 8/25/2014
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 8/25/2014
Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study 8/22/2014
Nuvilex (NVLX) Begins Preclinical Studies With Translational Drug Development To Determine If Nuvilex's Unique Cancer Treatment Can Slow Accumulation Of Malignant Ascites Fluid 8/20/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
Novan Therapeutics To Present Antiviral Preclinical Results Of Nitric Oxide-Releasing Drug Candidates For The Treatment Of Papillomavirus 8/14/2014
Nuvilex (NVLX) Provides Update On Status Of Preclinical Studies At Translational Drug Development 8/13/2014
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014
Scancell Release: Synergy Of SCIB1 With Checkpoint Inhibitors 8/12/2014
Cambridge's Sarepta Therapeutics (SRPT) Gets A Lift As Shelved Ebola Drug Offers Hope In Crisis 8/8/2014
PTC Therapeutics, Inc. (PTCT) Release: Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy 8/7/2014
Idera Pharmaceuticals, Inc. (IDRA) And Collaborators Publish Promising Preclinical Data Targeting Microrna With Gene Silencing Oligonucleotide Technology 8/6/2014
MediciNova, Inc. Announces Positive Results Of MN-001 In Advanced NASH Mouse Model; Medicinova Requests A Meeting With FDA 8/5/2014
Cannabis Science Inc. Initiates Pre-Clinical Studies On Cannabinoid Formulations In Neurological Diseases Including Sleep Disorders With The Highly Reputable Institute For Health And Science On Ageing - INRCA - In Italy 8/4/2014
NanoViricides, Inc. (NNVC.PK) To Restart Its Anti-Ebola Virus Drug Development Program 8/4/2014
Syndax Pharmaceuticals Inc. Release: Entinostat Improves Treatment Outcomes When Combined With Immune Checkpoint Blockade In Preclinical Tumor Models 7/30/2014
Advanced Biologics Publishes Additional Osteoamp® Abstracts In The Bone And Joint Journal 7/24/2014
Sirona Biochem Announces Successful Completion of Two First Line Studies By Wanbang Biopharmaceuticals 7/23/2014
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
La Jolla Pharmaceutical Company (LJPC) Announces Positive Pre-Clinical Data For Oral Galectin-3 Inhibitor In Nonalcoholic Steatohepatitis (NASH) 7/15/2014
Anavex Life Sciences Corp. (AVXL.OB) 3-71 Highly Effective And Disease-Modifying Against All Major Alzheimer's Hallmarks In Preclinical Disease Model 7/14/2014
BrainStorm Cell Therapeutics Inc. Announces Publication Of Preclinical Multidose Study Of NurOwn 7/11/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
Nuvilex (NVLX) Scheduled To Begin Preclinical Studies In Early August 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
Dicerna Pharmaceuticals (DRNA) Release: Researchers Demonstrate Promise Of Dicerna Investigational Therapy In Preclinical Model Of Primary Hyperoxaluria Type 1 (PH1) 6/30/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014
Flamel Technologies (FLML) Announces Positive Preclinical Results For Its Once-a-Week Formulation Of Exenatide 6/25/2014
Galectin Therapeutics Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 Is Efficacious In Preclinical Model Of Fatty Liver Disease With Fibrosis 6/23/2014



//-->